Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis

Table 3

Conditional logistic regression (CLR) for PLN MPO-ANCA by unit versus healthy controls, SLE without LN disease controls, and all controls together.

CLR for MPO-ANCA by unit: PLN versus controls	OR; (odds ratio)	CI; (confidence interval)	value
Healthy controls	9.1	3.4–24.5	<0.001
Disease controls	1.5	1.2–1.8	<0.001
All controls	7.1	1.2–44.2	<0.001